Article
Strategies for overcoming resistance in HIV-1 infected patients receiving HAART.
AIDS reviews - 1 Jan 2000
Clotet Bonaventura
Abstract excerpt
Highly active antiretroviral therapy (HAART) has fundamentally changed the clinical outcome of HIV infection and AIDS. However, the emergence of drug-resistant HIV variants is a barrier to successful use of HAART, with resistance to one drug often resulting in cross-resistance to many, if not all, others in the same class. The rise in the incidence of drug-resistant variants among newly infected patients also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
